May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Polyion Complex Micelle as Drug Delivery System for Corneal Neovasuculization
Author Affiliations & Notes
  • K. Sugisaki
    Ophthalmology, the university of Tokyo, Bunkyo–ku Hongou, Japan
  • T. Usui
    Ophthalmology,
    The University of Tokyo, Bunkyo–ku Hongou, Japan
  • K. Ono
    Ophthalmology,
    The University of Tokyo, Bunkyo–ku Hongou, Japan
  • T. Mimura
    Ophthalmology,
    The University of Tokyo, Bunkyo–ku Hongou, Japan
  • S. Yokoo
    Ophthalmology,
    The University of Tokyo, Bunkyo–ku Hongou, Japan
  • S. Yamagami
    Ophthalmology,
    The University of Tokyo, Bunkyo–ku Hongou, Japan
  • S. Amano
    Ophthalmology,
    The University of Tokyo, Bunkyo–ku Hongou, Japan
  • N. Nishiyama
    Engineering,
    The University of Tokyo, Bunkyo–ku Hongou, Japan
  • K. Kataoka
    Engineering,
    The University of Tokyo, Bunkyo–ku Hongou, Japan
  • Footnotes
    Commercial Relationships  K. Sugisaki, None; T. Usui, None; K. Ono, None; T. Mimura, None; S. Yokoo, None; S. Yamagami, None; S. Amano, None; N. Nishiyama, None; K. Kataoka, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 4486. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. Sugisaki, T. Usui, K. Ono, T. Mimura, S. Yokoo, S. Yamagami, S. Amano, N. Nishiyama, K. Kataoka; Polyion Complex Micelle as Drug Delivery System for Corneal Neovasuculization . Invest. Ophthalmol. Vis. Sci. 2005;46(13):4486.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:Corneal neovascularization (NV) is slightly–threatening condition, but there is few effective therapy in the clinical setting. Recently, nanocarriers consisting of polyion complex (PIC) micelles, composed of PEG–b–P(Asp) and the nano–scaled dendrimer porphyrin [NH2CH2CH2NHCO]32DPZn, have been demonstrated to effectively deliver dendrimer porphyrin photosensitizers into cancer cells and produce enhanced photodynamic efficacy. In this study, we examined the accumulation of dendrimer porphyrin photosensitizers in the corneal NV after systemic injection of PIC micelles encapsulating dendrimer porphyrins to investigate the feasibility of drug delivery to corneal NV using PIC nano–micelle. Methods:Corneal NV was induced in C57/B6 mice by placing an intrastromal nylon suture 1 mm away from the limbus. Four days after surgery, PIC micelles were administered by intravenous injection at the dose of 10mg/kg. For a control, the same amount of free dendrimer porphyrin was infused intravenously. To examine the accumulation of dendrimer porphyrin, corneas were excised 1,4,24 and 168 hours after injection, flat–mounted, stained with FITC–labeled BS–1 lectin, and observed with fluorescein microscopy. In the same model, photodynamic therapy was performed. 24 hours after the injection of PIC micelles encapsulating dendrimer porphyrin or free dendrimer porphyrin, 430 nm laser with 0.5 mm diameter was applied over the newly formed vessels in the cornea. The laser energy was 50 Jules/cm2. Before and 7 days after the laser treatment, the extent and the density of corneal neovascularization were examined with fluorescein angiography. Results:An hour after administration, fluorescence of dendrimer porphyrin started to accumulate in the vascularized area and enhanced until 24 hours after administration. The accumulation of dendrimer porphyrin decreased but remained after 168 hours. In contrast, dendrimer porphyrin was only vaguely detected in the area of neovascularization in the eyes receiving free dendrimer porphyrin. There was no fluorescence of micelles in normal limbal vessels. After PDT, the density of vessels decreased, but corneal vessels remained in the free dendrimer porphyrin group. In contrast, in the micelled dendrimer porphyrin group, few remaining vessels could be detected after PDT. Conclusions: The results suggest that PDT using dendrimer porphyrin encapsulated in PIC micelles can be an excellent therapy for corneal neovascularization.

Keywords: neovascularization • photodynamic therapy • cornea: basic science 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×